Sleep apnea is a pain.
Treatment shouldn’t be.
StimAire is the first truly patient-centric (and doctor-friendly) obstructive sleep apnea solution that doesn’t include CPAP, mouthpieces or surgery.
The StimAire system is an investigational device not currently approved for clinical use in any geography.
How it works
A better way to treat obstructive sleep apnea.
StimAire is a rice-grain-sized device that will be implanted via a simple injection under local anesthesia.
Early Wins • Exciting Traction
StimAire is committed to expanding treatment access for patients.
StimAire is rapidly heading toward launch—with FDA Breakthrough Device Designation. This designation is a formal identification by the U.S. FDA that a medical device in development should be expedited for patient access because it has a reasonable chance of providing more effective treatment than the standard of care for life-threatening or irreversibly debilitating diseases or conditions.
StimAire secured funding from institutional investor, UAVC.
Our patented injectable platform technology can be applied to other treatments.
StimAire has a clear path to regulatory approval.

About us
Committed to minimizing the burden of obstructive sleep apnea
StimAire is led by seasoned MDs, researchers and engineers specializing in sleep, neuromodulation, respiratory and ENT care.
We’re passionate about doing right by our patients. This passion drove us to create a superior alternative treatment for obstructive sleep apnea.
Our mission is to bring the very best that modern technology can offer for the benefit of patients and physicians. Our first offering will be for the treatment of obstructive sleep apnea.
News & Resources
Get the latest updates and information StimAire, sleep apnea information and more.